These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2006-003630-15 The effect of insulin analogues and human insulin on the incidence of severe hypoglycae-mia in hypoglycaemia prone type 1 diabetic patients 2011-11-08 due-trials
Completed, but no date 2007-004052-37 Effekten af Nexium og Cardi 04- Yoghurt på insulin sekretion og - virkning samt CVD risikofatorer associeret med insulinresistens syndromet for patienter med type 2 diabetes - Et randomiseret, dobbelt... bad-data
Not reported 2007-005677-59 Dobbeltblindet, randomiseret, enkeltcenter, investigator-sponsoreret studie af reaktioner ved applikationssted efter dyb samt superficiel subkutan og intradermal injektion af insulin detemir og saltva... 2009-03-10 due-trials
Not reported 2007-007146-34 Estudio aleatorizado del efecto del antagonista del receptor de interleucina 1 (anakinra, Kineret®) sobre la producción de insulina en pacientes con diabetes tipo 1 - The Anti-Interleukin-1 in Diabete... 2012-04-30 due-trials
Ongoing 2008-004434-24 The Anti-Interleukin-1 in Diabetes Action trial not-yet-due
Completed, but no date 2008-004839-38 Et randomiseret, dobbeltblindet, placebokontrolleret cross-over forsøg med Hexalacton til patienter med type 1 diabetes og mikroalbuminuri. bad-data
Completed, but no date 2009-011255-44 The effect of paricalcitol versus placebo on plasma NT-proBNP in patients with type 1 diabetes mellitus and diabetic nephropathy bad-data
Ongoing 2010-019956-32 Safety and efficacy of liraglutide as add-on to insulin and metformin therapy in type 2 diabetes patients not-yet-due
Not reported 2011-005344-95 Time course of the blood pressure lowering effect of liraglutide therapy in type 2 diabetes 2014-06-01 due-trials
Listed as ongoing, but also has a completion date 2012-000452-34 Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria 2018-10-29 bad-data
Not reported 2012-001150-26 Liraglutide in type 1 diabetes. A randomised, double-blind, placebo controlled study of the effect of liraglutide as an additional treatment to insulin on HbA1c, body weight and hypoglycaemia in poorl... 2015-04-01 due-trials
Reported results 2014-001786-26 A randomised, doublet blinded, placebo controlled cross-over study of Allopurinols effect to prevent loss of kidney function in type 1 diabetes 2016-08-12 due-trials
Not reported 2014-004502-15 Antiproteinuric Effects of Liraglutide Treatment in Patients with Type 2 Diabetes and Albuminuria: A Randomized, Placebo-Controlled Trial 2016-04-28 due-trials
Not reported 2015-000335-32 Effects of dapagliflozin treatment on urinary proteomic patterns in patients with type 2 diabetes 2017-08-29 due-trials
Ongoing 2015-001552-30 Effect of dapagliflozin, metformin and physical activity on glucose variability, body composition and cardiovascular risk in pre-diabetes (The PRE-D Trial) - A randomised, parallel, open-label, interv... not-yet-due
Exempt 2015-005580-16 A Phase 1b, open label, uncontrolled non-randomised single dose study to examine the safety of topically applied bone marrow derived allogeneic mesenchymal stromal cells (REDDSTAR ORBCEL-M) seeded in ... not-yet-due
Ongoing 2016-001523-31 Effect of liraglutide on vascular inflammation in type-2 diabetes: A randomized, placebo-controlled, double-blind, parallel clinical PET/CT trial not-yet-due